Sage Therapeutics (NASDAQ:SAGE) Stock Rating Upgraded by StockNews.com
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Friday. Several other equities analysts have also recently issued reports on the stock. Scotiabank decreased their target price on shares of Sage Therapeutics from $14.00 […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Friday. Several other equities analysts have also recently issued reports on the stock. Scotiabank decreased their target price on shares of Sage Therapeutics from $14.00 […]
